Bio-View Ltd (BIOV.TA)
ILA 30.4
(8.19%)
ILA 30.4
(8.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 153 Thousand | 968 Thousand | 3.24 Million | 802 Thousand | 2.49 Million | -1.32 Million |
| Net Income | 797 Thousand | 875 Thousand | 2.68 Million | 1.14 Million | 3.36 Million | -1.82 Million |
| Depreciation & Amortization | 1.81 Million | 1.49 Million | 1.47 Million | 1.22 Million | 1.4 Million | 541 Thousand |
| Deferred income taxes | -625 Thousand | -330 Thousand | -913 Thousand | -437 Thousand | -665 Thousand | - |
| Stock-based compensation | 6000.00 | 43 Thousand | 83 Thousand | 61 Thousand | 121 Thousand | 102 Thousand |
| Change in working capital | -1.95 Million | -1.35 Million | -314 Thousand | -1.23 Million | -1.79 Million | 228 Thousand |
| Other non-cash items | 110 Thousand | 236 Thousand | 232 Thousand | 46 Thousand | 63 Thousand | -370 Thousand |
| Investing Cash Flow | -1.67 Million | -567 Thousand | -740 Thousand | -313 Thousand | -226 Thousand | -194 Thousand |
| Investments in PPE | -274 Thousand | -457 Thousand | -659 Thousand | -304 Thousand | -208 Thousand | -180 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -1.74 Million | -19 Thousand | - | - | - | - |
| Sales/Maturities of investments | 334 Thousand | - | - | - | - | - |
| Other Investing Activities | 7000.00 | -91 Thousand | -81 Thousand | -9000.00 | -18 Thousand | -14 Thousand |
| Financing Cash Flow | -2.68 Million | -1.61 Million | -268 Thousand | -1.6 Million | -981 Thousand | 672 Thousand |
| Debt repayment | -1 Million | -1.35 Million | -268 Thousand | -1.02 Million | -1.04 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.74 Million | -256 Thousand | - | -671 Thousand | - | - |
| Common Stock Issuance | 65 Thousand | - | - | 98 Thousand | 66 Thousand | 672 Thousand |
| Other Financing Activities | 65 Thousand | -1.35 Million | - | -1.02 Million | -1.04 Million | 672 Thousand |
| Accounts receivables | -2.06 Million | -678 Thousand | -1.24 Million | 1 Million | -1.31 Million | 1.78 Million |
| Accounts payables | 2.06 Million | 678 Thousand | 1.24 Million | -1 Million | 1.31 Million | - |
| Inventory | -1.04 Million | -427 Thousand | -264 Thousand | -655 Thousand | -105 Thousand | -545 Thousand |
| Other working capital | -906 Thousand | -924 Thousand | -50 Thousand | -582 Thousand | -1.68 Million | 773 Thousand |
| Cash at beginning of period | 19.43 Million | 19.22 Million | 17.23 Million | 18.74 Million | 18 Million | 17.94 Million |
| Cash at end of period | 15.69 Million | 19.43 Million | 19.22 Million | 17.23 Million | 18.74 Million | 18 Million |
| Capital Expenditure | -274 Thousand | -457 Thousand | -659 Thousand | -304 Thousand | -208 Thousand | -180 Thousand |
| Effect of forex changes on cash | 456 Thousand | 1.42 Million | -255 Thousand | -393 Thousand | -553 Thousand | 912 Thousand |
| Net cash flow / Change in cash | -3.74 Million | 214 Thousand | 1.98 Million | -1.5 Million | 736 Thousand | 65 Thousand |
| Free Cash Flow | -121 Thousand | 511 Thousand | 2.58 Million | 498 Thousand | 2.28 Million | -1.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 980.5 Thousand | 980.5 Thousand | -537 Thousand | 797 Thousand | -537 Thousand | 728.5 Thousand |
| Depreciation & Amortization | 422 Thousand | 422 Thousand | 508.49 Thousand | 1.81 Million | 508.49 Thousand | 400.5 Thousand |
| Deferred income taxes | - | - | - | -625 Thousand | - | - |
| Stock-based compensation | 1000.00 | 1000.00 | -2500.00 | 6000.00 | -2500.00 | 5500.00 |
| Change in working capital | -515.5 Thousand | -515.5 Thousand | -841 Thousand | -1.95 Million | -841 Thousand | -1.19 Million |
| Other non-cash items | -1.23 Million | -1.23 Million | 596 Thousand | 110 Thousand | 596 Thousand | 409.5 Thousand |
| Investing Cash Flow | -388.5 Thousand | -388.5 Thousand | -717.5 Thousand | -1.67 Million | -717.5 Thousand | -119 Thousand |
| Investments in PPE | - | - | -30 Thousand | -274 Thousand | -30 Thousand | -107 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -1.74 Million | - | - |
| Sales/Maturities of investments | - | - | - | 334 Thousand | - | - |
| Other Investing Activities | -388.5 Thousand | -388.5 Thousand | -687.5 Thousand | 7000.00 | -687.5 Thousand | -12 Thousand |
| Financing Cash Flow | -544 Thousand | -544 Thousand | -331 Thousand | -2.68 Million | -331 Thousand | -1.01 Million |
| Debt repayment | - | - | - | -1 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -133 Thousand | -133 Thousand | -198 Thousand | -1.74 Million | -198 Thousand | -674 Thousand |
| Common Stock Issuance | - | - | - | 65 Thousand | - | - |
| Other Financing Activities | -411 Thousand | -411 Thousand | -133 Thousand | 65 Thousand | -133 Thousand | -336.5 Thousand |
| Accounts receivables | -59.5 Thousand | -59.5 Thousand | -328 Thousand | -2.06 Million | -328 Thousand | -706.5 Thousand |
| Accounts payables | - | - | - | 2.06 Million | - | - |
| Inventory | -1 Million | -1 Million | -484 Thousand | -1.04 Million | -484 Thousand | -39.5 Thousand |
| Other working capital | 553.5 Thousand | 553.5 Thousand | -29 Thousand | -906 Thousand | -29 Thousand | -445.5 Thousand |
| Cash at beginning of period | - | - | - | 19.43 Million | - | - |
| Cash at end of period | -1.07 Million | -1.07 Million | -1.39 Million | 15.69 Million | -1.39 Million | -475 Thousand |
| Capital Expenditure | - | - | -30 Thousand | -274 Thousand | -30 Thousand | -107 Thousand |
| Effect of forex changes on cash | 211 Thousand | 211 Thousand | -74 Thousand | 456 Thousand | -74 Thousand | 302 Thousand |
| Net cash flow / Change in cash | -1.07 Million | -1.07 Million | -1.39 Million | -3.74 Million | -1.39 Million | -475 Thousand |
| Free Cash Flow | -349 Thousand | -349 Thousand | -306 Thousand | -121 Thousand | -306 Thousand | 245.5 Thousand |
CDIIQ
PLNT
WSSH
CARV
CHD
RCEL